食品伙伴網(wǎng)訊  據(jù)歐盟食品安全局消息，2013年11月28日歐盟食品安全局就麻黃用于食品的安全性評估發(fā)表科學(xué)意見，認為麻黃及其制劑作為食品補充劑可能會對心血管和中樞神經(jīng)系統(tǒng)產(chǎn)生不良影響，所評估的使用量存在顯著的安全問題。

    部分原文報道如下：

    The ANS Panel provides a scientific opinion evaluating the safety in use of Ephedra herb and its preparations originating from Ephedra species when used in food, e.g. in food supplements. Ephedra species contain alkaloids of biological relevance: ephedrine, pseudoephedrine, norephedrine, norpseudoephedrine （cathine）， methylephedrine and methylpseudoephedrine. They have sympathomimetic activity and some of them are also used as active ingredients in medicinal products for which adverse effects are described.

    The use of Ephedra herb in food supplements is prohibited in several European countries, however food supplements containing Ephedra herb, also in combination with caffeine, are offered for sale via the internet. The Panel reviewed the available scientific data on a possible association between the intake of Ephedra herb, its preparations or its alkaloids and potential harmful effects on health. There is wide variation in the concentration of the individual ephedra alkaloids in different Ephedra species and in their preparations for use in food. No adequately specified individual preparations of Ephedra herb are known for which sufficient toxicological data for hazard characterisation exist.

    原文鏈接：http://www.efsa.europa.eu/en/efsajournal/pub/3467.htm